Hanaco and PayPal are set to exit Divvy, a provider of corporate spend management software, at a 56% premium to the valuation at which they invested in January.

The Takeda and Access Industries-backed oncology therapeutics developer is targeting an offering on the Nasdaq Global Market having previously raised $190m.

GV was among the investors in a series A round led by Andreessen Horowitz closed three years after the gene therapy developer's launch.

Nvidia participated in a round valuing the data storage technology provider, which counts Dell, Siemens and Mellanox as investors, at $3.7bn.

The Atrium Health-backed clinical trial software provider increased its overall funding to over $88m in a round led by Insight Partners.

The SK Telecom-backed app advertising and monetisation service provider is set to be bought by Zynga following $21m of venture funding.

The Chernin Group is set to exit the sports betting news platform provider it extablished four years ago, in a $240m acquisition deal.

Genetic sequencing platform developer TwinStrand has secured $50m in a series B round led by Section 32, while Alexandria Venture Investments invested for a third time.

Talaris has raised $150m in an initial public offering almost two decades after being spun out of University of Louisville as Regenerx.

Hella and Susquehanna International Group both took part in a series B round that increased the radar technology developer's overall funding to $75m.